| TRINETI JOHNSON & JOHNSON
1710708 14 Jan 2015 | on 19 Jun 2019 | Class 005 Class 005 Pharmaceutical Products Human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; anti-viral medications; anti-inflammatory medications; anti-pain medications; and anti-infective medications. | | | INVEGA TRINETI JOHNSON & JOHNSON
1710707 14 Jan 2015 | on 01 Aug 2018 | Class 005 Class 005 Pharmaceutical Products Human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; anti-viral medications; anti-inflammatory medications; anti-pain medications; and anti-infective medications. | | 
